Revised labels for epilepsy drugs obtain FDA clearance

05/5/2009 | Wall Street Journal, The

The FDA approved updated warning labels for epilepsy drugs, including Johnson & Johnson's Topamax, GlaxoSmithKline's Lamictal, and Novartis' Tegretol and Trileptal, that include information about a higher risk of suicidal tendencies. The agency said it is in talks with the companies about creating medication guides that educate patients about behavioral effects linked to the products.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Sr. Principal Electrical Engineer - 14000008LR
Abbott
San Jose, CA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA